Write in a clean editor, then format for JAMA Dermatology in one click — DocuGuru applies the official Clinical & Medical Journals template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JAMA Dermatology is a peer-reviewed journal published by Clinical & Medical Journals, covering Cutaneous Melanoma Detection and Management, Nonmelanoma Skin Cancer Studies, Autoimmune Bullous Skin Diseases. Over its lifetime it has published 4,974 papers, which have received 112,491 citations.
| Publisher | Clinical & Medical Journals |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. JAMA Dermatology. 2023;12(3):45–58.
Formats any DOI in JAMA Dermatology style. No sign-up. |
| Publishes research in | Cutaneous Melanoma Detection and Management Nonmelanoma Skin Cancer Studies Autoimmune Bullous Skin Diseases Dermatology and Skin Diseases Cutaneous lymphoproliferative disorders research |
| ISSN | 2168-6068 |
| Citation impact (2-yr) | 4.42 |
| h-index | 133 |
| i10-index | 1,998 |
| Top institutions publishing here | Harvard University |
| Journal website | archderm.ama-assn.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
IMPORTANCE: Understanding skin cancer incidence is critical for planning prevention and treatment strategies and allocating medical resources. However, owing to lack of national reporting and previously nonspecific diagnosis classification, accurate measurement of the US incidence of nonmelanoma skin cancer (NMSC) has been difficult. OBJECTIVE: To estimate the incidence of NMSC (keratinocyte carcinomas) in the US…
Importance: Despite many cases being preventable, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is vital to concentrate and reinforce global prevention efforts. Objective: To examine global patterns of cutaneous melanoma in 2020 and to provide projected estimates of cases and deaths by 2040. Design, Setting,…
Importance: Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin diseases. Objective: To measure the burden of skin diseases worldwide. Data Sources: For nonfatal estimates, data were found by literature search using PubMed and Google Scholar in English and…
IMPORTANCE: Vitiligo is an autoimmune skin disorder that reacts against melanocytes. The association of vitiligo with tumor response in patients with melanoma who undergo immunotherapy has been reported but is still controversial. OBJECTIVE: To prospectively evaluate the appearance of vitiligo in patients receiving pembrolizumab, a monoclonal antibody directed against the programmed death cell receptor. DESIGN,…
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA…
